An adult male, aged 48 years, is evaluated in the outpatient clinic for a 6-month history … — USMLE Step 3

An adult male, aged $48$ years, is evaluated in the outpatient clinic for a $6$ -month history of progressive fatigue, decreased libido, and arthralgias affecting the second and third metacarpophalangeal joints of both hands. He has no prior medical conditions and takes no medications. He reports drinking $1$ to $2$ glasses of wine on weekends. Vital signs are within normal limits. Physical examination reveals mildly hyperpigmented skin on sun-exposed areas and a palpable liver edge $2$ cm below the right costal margin. There is no splenomegaly.

Laboratory studies show:
Hemoglobin: $15.2$ g/dL
Platelet count: $210,000$ /mm $^3$
Aspartate aminotransferase (AST): $58$ U/L
Alanine aminotransferase (ALT): $65$ U/L
Fasting transferrin saturation: $75\%$ (Normal: $20$ - $50\%$ )
Serum ferritin: $1,350$ ng/mL (Normal: $20$ - $250$ ng/mL)

Targeted molecular diagnostic testing confirms that the patient is homozygous for a C282Y missense mutation. Which of the following statements best characterizes the molecular mechanism and the appropriate diagnostic approach for this patient's underlying condition?

A
The genetic alteration induces hepatic cytochrome P450 enzymes, meaning the primary clinical focus should be avoiding severe pharmacokinetic drug interactions.
B
The mildly elevated transaminases indicate a dominant-negative structural mutation in hepatocytes, which causes primary spontaneous lysis and secondary ferritin elevation.
The mutation impairs the cell surface localization of a regulatory protein, resulting in decreased hepcidin synthesis and necessitating evaluation for systemic complications.Cevap
D
The disease exhibits extensive locus heterogeneity, which mandates that an invasive percutaneous liver biopsy be performed prior to any non-invasive confirmation.
E
The syndrome is caused by a localized somatic mosaicism affecting only the liver and synovium, safely allowing the restriction of further diagnostic evaluation to these organs.

Cevap

The mutation impairs the cell surface localization of a regulatory protein, resulting in decreased hepcidin synthesis and necessitating evaluation for systemic complications.

The patient has hereditary hemochromatosis, most commonly caused by a homozygous C282Y missense mutation in the HFE gene. The HFE protein normally binds to the transferrin receptor to regulate iron absorption. The mutation causes protein misfolding and prevents its proper localization to the cell surface. This loss of function leads to a false intracellular signal of low iron stores, resulting in decreased synthesis of hepcidin by the liver. Low hepcidin levels cause uninhibited ferroportin activity on the basolateral surface of enterocytes, leading to excessive iron absorption. Because iron accumulation systemically affects the liver, pancreas, heart, and pituitary gland, patients must be comprehensively evaluated for systemic complications such as diabetes mellitus, cardiomyopathy, and hypogonadism.

Adım Adım Çözüm

Identify the patient's underlying diagnosis based on the clinical presentation and laboratory findings.

The combination of fatigue, arthralgias in the 2nd/3rd metacarpophalangeal joints, skin hyperpigmentation, elevated transferrin saturation (

75\%

), markedly elevated ferritin (

1,350

ng/mL), and a homozygous C282Y mutation confirms the diagnosis of Hereditary Hemochromatosis.

Recognizing the disease is the essential first step before evaluating its specific molecular pathophysiology.

Determine the specific molecular consequence of the C282Y mutation in the HFE gene.

The mutation prevents proper folding and cell surface localization of the HFE protein. This disrupts its interaction with the transferrin receptor, causing a false signal of low systemic iron and consequently suppressing hepcidin production by the liver.

Understanding the exact molecular defect bridges the foundational science to the clinical presentation.

Relate the molecular defect to the appropriate clinical management approach.

Deficient hepcidin leads to uninhibited iron absorption and systemic deposition. Therefore, the physician must evaluate the patient for systemic complications such as diabetes mellitus, cardiomyopathy, and hypogonadism.

The question asks for both the molecular mechanism and the appropriate diagnostic approach to ensure comprehensive patient care.

Anahtar Kavram

Molecular Pathophysiology of Hereditary Hemochromatosis (HFE gene mutation)

Tahmini Süre:1m 30s

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru